Prescription drug · ANDA
Methimazole NDC 71335-0883
Methimazole 10 mg/1 · Tablet · Oral · Bryant Ranch Prepack
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 71335-0883-1 | 71335088301 | 30 TABLET in 1 BOTTLE (71335-0883-1)Marketed from Jun 25, 2018 | |
| 71335-0883-2 | 71335088302 | 15 TABLET in 1 BOTTLE (71335-0883-2)Marketed from Nov 29, 2018 | |
| 71335-0883-3 | 71335088303 | 90 TABLET in 1 BOTTLE (71335-0883-3)Marketed from Sep 10, 2020 |
How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Methimazole
- Generic name (nonproprietary)
- methimazole
- Active ingredients
- Methimazole — 10 mg/1
- Dosage form
- Tablet
- Route
- Oral
- Labeler
- Bryant Ranch Prepack
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 040734
- Marketing start
- Listing expires
- Other FDA classes
- Thyroid Hormone Synthesis Inhibitors (Mechanism)
- Identifiers
- Product ID 71335-0883_73e30786-8309-4943-8ae0-2cb376563217SPL ID 73e30786-8309-4943-8ae0-2cb376563217SPL set ID 381052c4-891c-4ae4-b63e-65229126cbcaRxCUI 197941UNII 554Z48XN5E
- Pharmacologic class
- Thyroid Hormone Synthesis Inhibitor
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N471335088301followed by a unit qualifier and the quantityPackage 71335-0883-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS AND USAGE Methimazole tablets are indicated: In patients with Graves' disease with hyperthyroidism or toxic multinodular goiter for whom surgery or radioactive iodine therapy is not an appropriate treatment option. To ameliorate symptoms of hyperthyroidism in preparation for thyroidectomy or radioactive iodine therapy.
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 040734
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Methimazole | Methimazole 5 mg/1 | TabletOral | Bryant Ranch Prepack | 63629-8347 |
| Methimazole | Methimazole 5 mg/1 | TabletOral | NORTHSTAR RX LLC | 72603-315 |
| Methimazole | Methimazole 10 mg/1 | TabletOral | NORTHSTAR RX LLC | 72603-316 |
| Methimazole | Methimazole 5 mg/1 | TabletOral | Golden State Medical Supply, Inc. | 60429-380 |
| Methimazole | Methimazole 10 mg/1 | TabletOral | Golden State Medical Supply, Inc. | 60429-381 |
| Methimazole | Methimazole 5 mg/1 | TabletOral | Preferred Pharmaceuticals Inc. | 68788-8226 |
| Methimazole | Methimazole 10 mg/1 | TabletOral | Preferred Pharmaceuticals Inc. | 68788-8227 |
| Methimazole | Methimazole 10 mg/1 | TabletOral | Proficient Rx LP | 82804-231 |
| Methimazole | Methimazole 5 mg/1 | TabletOral | A-S Medication Solutions | 50090-6536 |
| Methimazole | Methimazole 10 mg/1 | TabletOral | REMEDYREPACK INC. | 70518-1475 |
| Methimazole | Methimazole 5 mg/1 | TabletOral | REMEDYREPACK INC. | 70518-1506 |
| Methimazole | Methimazole 10 mg/1 | TabletOral | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 23155-071 |
| Methimazole | Methimazole 5 mg/1 | TabletOral | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 23155-070 |